Literature DB >> 11575858

Contralateral papillary thyroid cancer is frequent at completion thyroidectomy with no difference in low- and high-risk patients.

F Pacini1, R Elisei, M Capezzone, P Miccoli, E Molinaro, F Basolo, L Agate, V Bottici, M Raffaelli, A Pinchera.   

Abstract

Total (or near-total) thyroidectomy (TT) is considered by many as the most adequate treatment for papillary thyroid carcinoma (PTC). In patients who have undergone lobectomy, the necessity of performing a completion thyroidectomy (CT) is still discussed. The aim of this retrospective study was to evaluate tumor bilaterality in patients initially treated with partial thyroidectomy for PTC and who then underwent CT. We studied 182 patients treated with CT after lobectomy and/or isthmectomy for PTC diagnosed from 1969-1998. Mean age at diagnosis was 40+/-14.5 years and mean interval between partial thyroidectomy and CT was 19.8+/-56.8 months. At CT, 80 of 182 patients (44%) had one or more foci of tumor in the remaining thyroid lobe, always of the same papillary histotype, associated with ipsilateral lymph node metastases in 22 cases. In addition, 10 patients with no tumoral foci in the thyroid specimen had evidence of lymph node metastases. The rate of bilateral tumor was not different when patients were analyzed according to the classification of "low-" or "high-risk." Among several clinical features, the presence of lymph node metastases at the first surgical treatment and time interval between first treatment and CT were correlated with higher frequency of bilaterality (p = 0.033 and p = 0.044, respectively). The postsurgical 131I whole-body scan revealed the presence of persistent lymph node metastases or diffuse micronodular lung metastases in 7 and 6 patients, respectively. In conclusion, PTC was frequently bilateral in our series and this bilaterality was independent from the "low-" or "high-risk" classification. On these bases, we believe that PTC should be treated with TT when diagnosed before surgery and submitted to CT, if partial surgery was the initial intervention.

Entities:  

Mesh:

Year:  2001        PMID: 11575858     DOI: 10.1089/105072501316973145

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  27 in total

Review 1.  Best practice in thyroid pathology.

Authors:  C E Anderson; K M McLaren
Journal:  J Clin Pathol       Date:  2003-06       Impact factor: 3.411

2.  Extent of surgery for differentiated thyroid cancer: recommended guideline.

Authors:  Ganiyu A Rahman
Journal:  Oman Med J       Date:  2011-01

Review 3.  Managing newly diagnosed thyroid cancer.

Authors:  Anna M Sawka; James D Brierley; Shereen Ezzat; David P Goldstein
Journal:  CMAJ       Date:  2013-10-07       Impact factor: 8.262

4.  Extent of Thyroidectomy in Differentiated Thyroid Cancers-Review of Evidence.

Authors:  Samskruthi P Murthy; Deepak Balasubramanian; Adharsh Anand; Shashikant Vishnubhai Limbachiya; Narayana Subramaniam; Vasantha Nair; Krishnakumar Thankappan; Subramania Iyer
Journal:  Indian J Surg Oncol       Date:  2017-05-09

5.  How many contralateral papillary thyroid carcinomas can be missed?

Authors:  Kwan Ju Lee; Yun Jung Cho; Jeong Goo Kim; Dong Ho Lee
Journal:  World J Surg       Date:  2013-04       Impact factor: 3.352

6.  Bilaterality weighs more than unilateral multifocality in predicting prognosis in papillary thyroid cancer.

Authors:  Ning Qu; Ling Zhang; Wei-Li Wu; Qing-Hai Ji; Zhong-Wu Lu; Yong-Xue Zhu; Dao-Zhe Lin
Journal:  Tumour Biol       Date:  2016-01-07

7.  Video-assisted thyroidectomy for papillary thyroid carcinoma.

Authors:  R Bellantone; C P Lombardi; M Raffaelli; P F Alesina; C De Crea; E Traini; M Salvatori
Journal:  Surg Endosc       Date:  2003-07-21       Impact factor: 4.584

Review 8.  Multifocal papillary thyroid carcinoma--a consensus report of the European Society of Endocrine Surgeons (ESES).

Authors:  Maurizio Iacobone; Svante Jansson; Marcin Barczyński; Peter Goretzki
Journal:  Langenbecks Arch Surg       Date:  2013-11-22       Impact factor: 3.445

9.  Intrathyroidal differentiated thyroid carcinoma: tumor size-based surgical concepts.

Authors:  Paolo Miccoli; Michele N Minuto; Clara Ugolini; Erica Panicucci; Piero Berti; Marco Massi; Fulvio Basolo
Journal:  World J Surg       Date:  2007-05       Impact factor: 3.352

10.  Contralateral papillary thyroid cancer: does size matter?

Authors:  Susan C Pitt; Rebecca S Sippel; Herbert Chen
Journal:  Am J Surg       Date:  2009-03       Impact factor: 2.565

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.